Another study found that YTHDC2 was highly expressed in human colon cancer tissues; a significantly positive correlation was detected between YTHDC2 expression and colon cancer stage, suggesting that YTHDC2 was potentially a diagnostic marker and target gene for treating colon cancer (Tanabe et al., 2016). This evidence concerns the gene YTHDC2 and malignant colon neoplasm.